Tuesday, July 16, 2019
Emerging Growth Biotech

Marina Biotech to Acquire Late-Stage Program From Turing Pharmaceuticals

Marina to Pursue Phase 3 Studies for Use of Intranasal Ketamine in Multiple Indications BOTHELL, WA, and BAAR, SWITZERLAND--(Marketwired - May 3, 2016) - Marina...
Emerging Growth Biotech

Marina Biotech Terminates Negotiations for Sale of Its Nucleic Acid Therapeutic Assets

BOTHELL, WA--(Marketwired - May 3, 2016) - Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare...
Propanc Health Group Corporation PPCH Prepares for Scientific Advice Meeting and Additional Upcoming Milestones

Propanc Files Two More Patents Citing New Compositions of Proenzymes for Cancer Treatment

Company Prepares for Scientific Advice Meeting and Additional Upcoming Milestones MELBOURNE, Australia, April 19, 2016 /PRNewswire/ -- Propanc Health Group Corporation (PPCH) ("Propanc" or "the Company"),...

MOST POPULAR